Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,146 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02883335Recruiting
MS registry for people living in Lorraine
This study is a registry that collects information from people who have multiple sclerosis (MS). It helps researchers better understand MS in the Lorraine region and may guide future care.
NancyAges Any age - NCT05236153Recruiting
Study of heart valve procedure in repaired Tetralogy of Fallot
This study looks at how a transcatheter pulmonary valve replacement works in people with repaired Tetralogy of Fallot or double outlet right ventricle. The goal is to better understand the heart’s anatomy and how it may affect the valve procedure.
Boston, MassachusettsAges Any age - NCT05445544Recruiting
Study of belly and baby microbes to improve preeclampsia screening
This study looks at tiny living organisms in pregnancy (and related body samples) to find better ways to screen for preeclampsia. By learning early warning signs, it may help doctors identify risk sooner during routine prenatal care.
Guangzhou, GuangdongAges 18 years+ - NCT05614193Recruiting
Deep imaging study for suspected stroke patients
This trial studies an advanced way to analyze CT or MRI scans for people who may have had a stroke or reduced blood flow to the brain. It aims to improve how scans are interpreted and shared for better care.
Beijing, Beijing MunicipalityAges 18–100 - NCT05717790Recruiting
Nimotuzumab with chemo and radiation for advanced nose cancer
This trial tests whether adding nimotuzumab (an anti-EGFR antibody) to standard chemotherapy and radiation can improve outcomes for people with advanced nasopharyngeal carcinoma. It may help the cancer respond better and control it more effectively after treatment.
Baise City, GuangxiAges 18–70 - NCT03820492Recruiting
Testing imaging tools to assess a narrowed left main artery
This trial compares different heart scans to decide how serious a narrowing is in the left main coronary artery. It may help doctors choose the safest and most accurate way to manage that blockage during a heart catheter procedure.
Clermont-FerrandAges 18 years+ - NCT05272202RecruitingEarly Phase 1
Study brain signals after median nerve stimulation during anesthesia
This early-stage study checks how brain activity changes when the median nerve is gently stimulated while you’re under general anesthesia with propofol. It may help researchers better understand brain–nerve connections and improve how these signals are measured.
BrusselsAges 18–81 - NCT04607538Recruiting
Study of knee joint shape and patella dislocations in Faroese teens
This study looks at how knee joint shape differences may relate to repeated kneecap (patella) instability or near-dislocation, and what that means long-term. It specifically includes teens from the Faroe Islands and asks about symptoms and knee function over time.
HvidovreAges 15–20 - NCT03466424Recruiting
Short radiation then chemotherapy for locally advanced rectal cancer
This trial tests a short course of radiation given before chemotherapy for people with locally advanced rectal cancer (cancer that has grown into nearby tissue and/or nearby lymph nodes but can still be removed). It may help shrink the tumor and make treatment more effective while assessing how well this approach works.
Fuzhou, FujianAges 18–70 - NCT04743102Recruiting
Multi-point full-thickness biopsy to confirm complete rectal cancer response
This trial checks whether taking small samples from the full thickness of rectal tissue can accurately confirm that rectal cancer has fully responded to chemotherapy and/or radiation. It may help doctors decide the best next step if no tumor is seen after treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT05731258Recruiting
Watch how liposomal doxorubicin is used after breast cancer
This is an observational study that follows people receiving add-on (adjuvant) chemotherapy after primary breast cancer. It aims to understand treatment patterns and outcomes for patients healthy enough to receive liposomal doxorubicin and who have no major complications.
Hangzhou, ZhejiangAges 18–75 - NCT05731245RecruitingPhase 2
Ropeginterferon for early myelofibrosis with low-to-mid risk
This Phase 2 trial studies ropeginterferon alfa-2b (a type of interferon medicine) in adults with early, lower-risk myelofibrosis. The goal is to see if it can control the disease better or improve outcomes with an acceptable safety profile.
Taipei, Taiwan, 100Ages 20 years+ - NCT04501523RecruitingPhase 2
ctDNA-guided immunotherapy boost after chemotherapy for triple-negative breast cancer
This Phase 2 study checks whether a blood test that looks for cancer DNA (ctDNA) can help decide who should get an extra 12-month immunotherapy treatment after standard chemotherapy and surgery. It may help reduce the chance of the cancer coming back in people with triple-negative breast cancer.
Guandong, GuangdongAges 18–80 - NCT05734365Recruiting
COPD patients admitted to ICU after a flare, for registry
This observational study collects information on people with COPD (chronic lung disease) who have a severe flare requiring ICU care. It does not test a new drug, but the data may help doctors better understand severe COPD episodes and ICU outcomes.
Le ChesnayAges 40 years+ - NCT04803539RecruitingPhase 2/Phase 3
ctDNA-guided booster treatment after chemo for triple-negative breast cancer
This trial uses a blood test called ctDNA to see who is at higher risk after surgery and standard chemotherapy for triple-negative breast cancer. If your ctDNA test is positive, you may receive an extra “boost” treatment to help reduce the chance the cancer returns.
Guandong, GuangdongAges 18–80 - NCT05202314Recruiting
Camrelizumab plus chemo after stent for left bowel cancer
This study tests whether adding camrelizumab (an immune therapy) to chemotherapy—after a stent is placed to open a blocked left-sided colon—improves outcomes. It’s meant for people whose cancer can still be removed with surgery after the blockage is treated.
Beijing, Beijing MunicipalityAges 18–80 - NCT05589207Recruiting
Model to predict outcomes in kidney cancer with IVC wall invasion
This study uses information from scans and surgery findings to build a prediction model for people with kidney cancer that has grown into a major vein (the IVC). It aims to help doctors better estimate outcomes and guide care after surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05735145RecruitingPhase 3
Chemo plus radiation, then extra chemo for advanced cervical cancer
This Phase 3 study looks at whether adding chemotherapy after standard chemo-radiation can improve outcomes for advanced cervical cancer. You might be eligible if your cancer responded fully to initial treatment and you meet safety and health requirements.
Liuzhou, GuangxiAges 18–75 - NCT05736627Recruiting
Compare learning from in-person versus online medical training
This study looks at whether people learn better from in-person training or online training in a medical setting. You may help by taking a course and sharing whether the format affects what you learn.
Frederiksberg, Frederiksberg HospitalAges 18 years+ - NCT05725200RecruitingPhase 2
Personalized treatment plan for metastatic colon or rectal cancer
This Phase 2 trial tests an individualized treatment chosen from your tumor’s lab testing (genetic and RNA profile plus a drug-sensitivity test from your tumor cells). It may help by matching you to targeted anti-cancer drugs that are most likely to work for your specific cancer.
OsloAges 18 years+ - NCT04628078Recruiting
Echocardiogram-guided heart procedure registry for atrial fibrillation
This study keeps a real-world record of people with atrial fibrillation who are planning a procedure to close off the heart’s left atrial appendage. Doctors use echocardiography (heart ultrasound) to guide the closure and track outcomes to improve care.
BernAges 18 years+ - NCT05672485Recruiting
Scan prostate cancer using a radioactive tracer SPECT/CT
This trial uses a special imaging scan (SPECT/CT) with a small amount of radioactive tracer to look at prostate cancer. It aims to see how well the scan matches your prostate cancer tests and may help improve detection and assessment.
Xi'an, ShaanxiAges 18 years+ - NCT05738980Recruiting
Reduce liver cancer return after surgery using anti–TIM-3
This trial studies whether blocking TIM-3 (an immune “brake”) can help stop hepatocellular carcinoma (liver cancer) from coming back after a curative surgery. It may help by improving your immune system’s ability to find and control remaining cancer cells.
Beijing, Beijing MunicipalityAges 18–75 - NCT05574582Recruiting
Keyhole versus open surgery for an unhealed scaphoid bone
This study compares two surgical approaches—keyhole surgery versus open surgery—for scaphoid fractures that are not healing on their own. It aims to see which approach better helps the scaphoid heal after a delay or complete non-healing.
HellerupAges 18–68
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,146 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.